These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22834841)

  • 1. The influence of macrophages and the tumor microenvironment on natural killer cells.
    Krneta T; Gillgrass A; Ashkar AA
    Curr Mol Med; 2013 Jan; 13(1):68-79. PubMed ID: 22834841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor cells and tumor microenvironment on NK-cell function.
    Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L
    Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cells and solid tumors.
    Stojanovic A; Cerwenka A
    J Innate Immun; 2011; 3(4):355-64. PubMed ID: 21502747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human bone marrow stromal cells and skin fibroblasts inhibit natural killer cell proliferation and cytotoxic activity.
    Pradier A; Passweg J; Villard J; Kindler V
    Cell Transplant; 2011; 20(5):681-91. PubMed ID: 21054933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
    Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
    Pietra G; Manzini C; Rivara S; Vitale M; Cantoni C; Petretto A; Balsamo M; Conte R; Benelli R; Minghelli S; Solari N; Gualco M; Queirolo P; Moretta L; Mingari MC
    Cancer Res; 2012 Mar; 72(6):1407-15. PubMed ID: 22258454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
    J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell immune escape in acute myeloid leukemia.
    Lion E; Willemen Y; Berneman ZN; Van Tendeloo VF; Smits EL
    Leukemia; 2012 Sep; 26(9):2019-26. PubMed ID: 22446501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human NK cells and NK receptors.
    Bellora F; Castriconi R; Dondero A; Carrega P; Mantovani A; Ferlazzo G; Moretta A; Bottino C
    Immunol Lett; 2014 Oct; 161(2):168-73. PubMed ID: 24361820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK Cell Metabolism and Tumor Microenvironment.
    Terrén I; Orrantia A; Vitallé J; Zenarruzabeitia O; Borrego F
    Front Immunol; 2019; 10():2278. PubMed ID: 31616440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector and regulatory events during natural killer-dendritic cell interactions.
    Moretta L; Ferlazzo G; Bottino C; Vitale M; Pende D; Mingari MC; Moretta A
    Immunol Rev; 2006 Dec; 214():219-28. PubMed ID: 17100887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functions of natural killer cells.
    Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
    Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell-based cancer immunotherapy.
    Stagg J; Smyth MJ
    Drug News Perspect; 2007 Apr; 20(3):155-63. PubMed ID: 17520092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell receptors as tools in cancer immunotherapy.
    Sentman CL; Barber MA; Barber A; Zhang T
    Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.
    Pasero C; Gravis G; Guerin M; Granjeaud S; Thomassin-Piana J; Rocchi P; Paciencia-Gros M; Poizat F; Bentobji M; Azario-Cheillan F; Walz J; Salem N; Brunelle S; Moretta A; Olive D
    Cancer Res; 2016 Apr; 76(8):2153-65. PubMed ID: 27197252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of NK-cell function by mucins via antigen-presenting cells.
    Laskarin G; Redzovic A; Medancic SS; Rukavina D
    Med Hypotheses; 2010 Dec; 75(6):541-3. PubMed ID: 20702048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.